Septerna (SEPN) Change in Cash (2023 - 2026)
Septerna's quarterly Change in Cash came in at -$49.1 million in Q1 2026, down 74.48% year-on-year from -$192.4 million in Q1 2025, and up 75.35% quarter-over-quarter from -$199.3 million in Q4 2025.
Septerna has reported Change in Cash for 4 years, with the latest figure at -$49.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 74.48% year-over-year to -$49.1 million; the trailing twelve-month figure through Mar 2026 stood at -$138.4 million (down 207.56% YoY), and the FY2025 full-year result was -$117.5 million, down 178.47% from the prior year.
- Change in Cash for Q1 2026 stood at -$49.1 million, up from -$199.3 million in the prior quarter.
- The five-year high for Change in Cash was $150.0 million in Q4 2024, with the low at -$199.3 million in Q4 2025.
- Average Change in Cash over 4 years is -$2.7 million, with a median of -$15.4 million recorded in 2023.
- Year-over-year, Change in Cash jumped 1594.16% in 2024 and sank 294.11% in 2025.
- Tracing SEPN's Change in Cash over 4 years: stood at -$10.0 million in 2023, then jumped by 1594.16% to $150.0 million in 2024, then slumped by 232.89% to -$199.3 million in 2025, then soared by 75.35% to -$49.1 million in 2026.
- The last three Change in Cash figures came in at -$49.1 million (Q1 2026), -$199.3 million (Q4 2025), and $130.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | -49.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.12 Mn |
| Dec 31, 2025 | -199.27 Mn |
| Sep 30, 2025 | 130.68 Mn |
| Jun 30, 2025 | -20.73 Mn |
| Mar 31, 2025 | -28.15 Mn |
| Dec 31, 2024 | 149.95 Mn |
| Sep 30, 2024 | -42.93 Mn |
| Jun 30, 2024 | 49.83 Mn |
| Mar 31, 2024 | -7.14 Mn |
| Dec 31, 2023 | -10.04 Mn |